← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9025 | 71266-9025-5 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin; Epinephrine; Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-03 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-523 | 69374-523-21 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-012 | 72055-012-05 | Iohexol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:651 | 651 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:651 | 651 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:652 | 652 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-033 | 70713-033-01 | TESTOSTERONE SA2 62.5MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:652 | 652 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-06 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:652 | 652 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-513 | 69374-513-50 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-012 | 72055-012-02 | Iohexol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2011 | 71286-2011-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-250 | 73702-250-15 | Ketamine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-887 | 69194-887-01 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:652 | 652 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:652 | 652 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:652 | 652 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:653 | 653 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-09 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:653 | 653 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1373 | 61141-1373-5 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-09 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-55 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Dextrose Monohydrate; Histidine; Arginine; Taurine; Leucine; Methionine; Proline; Aspartic Acid | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:653 | 653 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6616 | 71300-6616-4 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:653 | 653 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:653 | 653 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:654 | 654 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0329 | 83863-0329-1 | Neostigmine Methylsulfate 5 mg in 5 mL (1mg/mL) | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-604 | 70004-604-12 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:654 | 654 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-03 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-244 | 70004-244-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-982 | 69374-982-33 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:654 | 654 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-28 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-302 | 73702-302-31 | Ketamine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:654 | 654 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:654 | 654 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:654 | 654 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:654 | 654 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:655 | 655 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2322 | 72627-2322-5 | Semaglutide/Cyanocobalamin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-605 | 70004-605-09 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-903 | 69374-903-05 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-07 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-118 | 70731-118-55 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-030 | 71170-030-05 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:655 | 655 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-117 | 73177-117-27 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-117 | 70092-117-79 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-301 | 73702-301-15 | Ketamine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:655 | 655 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:655 | 655 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7559 | 72934-7559-6 | Levocetirizine Dihydrochloride; Clobetasol Propionate | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:655 | 655 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:656 | 656 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5340 | 71139-5340-4 | Fentanyl Citrate with Ropivacaine Hydrochlorid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-040 | 71170-040-05 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-821 | 54288-821-01 | Isosulfan Blue | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-529 | 65302-529-05 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:656 | 656 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:656 | 656 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6676 | 71300-6676-2 | Lidocaine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:657 | 657 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5340 | 71139-5340-2 | Fentanyl Citrate with Ropivacaine Hydrochlorid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-253 | 70004-253-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2002 | 73013-2002-3 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2001 | 73013-2001-3 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:657 | 657 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:657 | 657 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6726 | 71300-6726-2 | Lidocaine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:658 | 658 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-10 | Phenylephrine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:658 | 658 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72918-1003 | 72918-1003-1 | Glutathione | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:658 | 658 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-023 | 71506-023-03 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:658 | 658 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-32 | Ketamine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2002 | 73013-2002-2 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:658 | 658 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-4 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5534 | 72934-5534-4 | Lidocaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:658 | 658 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:659 | 659 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin 5000units added to NS | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3325 | 62295-3325-5 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2018 | 73013-2018-1 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:659 | 659 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:659 | 659 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-03 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:660 | 660 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-020 | 72055-020-01 | Sugammadex | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:660 | 660 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-2 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:660 | 660 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:660 | 660 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4010 | 72627-4010-9 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-0 | Ketamine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-30 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:660 | 660 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:660 | 660 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:660 | 660 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:661 | 661 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1229 | 73271-1229-1 | TESTOSTERONE CYPIONATE/PROPIONATE 200 MG/10 MG/ML MIGLYOL 812N | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:661 | 661 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:661 | 661 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-1 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:661 | 661 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:661 | 661 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-308 | 69374-308-05 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-302 | 73702-302-31 | Ketamine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:661 | 661 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2018 | 73013-2018-1 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-3 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:661 | 661 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:661 | 661 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6006 | 72196-6006-1 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:662 | 662 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-010 | 71449-010-11 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8610 | 71266-8610-1 | Glycerin | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-09 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:662 | 662 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-260 | 70004-260-32 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4003 | 72627-4003-3 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-301 | 73702-301-15 | Ketamine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:662 | 662 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2000 | 73013-2000-2 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6676 | 71300-6676-2 | Lidocaine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:662 | 662 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:663 | 663 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-389 | 73693-389-01 | TESTOSTERONE 25 MG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-014 | 71449-014-11 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1486 | 5446-1486-01 | Glycerin | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-638 | 70004-638-06 | Glycopyrrolate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-782 | 76154-782-75 | Glycopyrrolate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:663 | 663 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:663 | 663 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:663 | 663 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4003 | 72627-4003-7 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:663 | 663 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2022-2 | source_no_ndc | 1 | 2026-10-15 |